ABXL
NONEABXL
AI Insight
What's Moving ABXL Today?
No stock-specific AI insight has been generated for ABXL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$21.59$25.68
$25.48
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield9.47%
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume10K
Avg Volume (10D)—
Shares Outstanding—
ABXL News
10 articles- Abacus Global Management to Participate in the Northland Growth Conference 2026GlobeNewswire·Jun 11, 2026
- Abacus Global (ABX) awards 1M performance rights tied to 2026Stock Titan·Jun 5, 2026
- [Form 4] Abacus Global Management, Inc. Insider Trading ActivityStock Titan·Jun 5, 2026
- Abacus Global Management (ABL) CFO awarded 1M performance rights tied to 2026 goalsStock Titan·Jun 5, 2026
- Abacus Global (ABX) CEO receives 2M performance rights tied to 2026 goalsStock Titan·Jun 5, 2026
- Abacus Global (NYSE: ABL) holders back 2026 equity plan and pay votesStock Titan·Jun 4, 2026
- Earnings Flash (ABX) Abacus Global Management, Inc. Posts Q1 Adjusted EPS $0.20 per Share, vs. FactSet Est of $0.21marketscreener.com·May 7, 2026
- Earnings Flash (ABX) Abacus Global Management, Inc. Reports Q1 Revenue $59.4M, vs. FactSet Est of $64.2Mmarketscreener.com·May 7, 2026
- Abacus Chairman and CEO to Speak at the Milken Institute Global Conference in Los AngelesGlobeNewswire Inc.·May 1, 2026
- Abacus Global Management, Inc. Investigated by the Portnoy Law FirmGlobeNewswire Inc.·Mar 26, 2026
All 10 articles loaded
Price Data
Open$25.42
Previous Close$25.49
Day High$25.50
Day Low$25.42
52 Week High$25.68
52 Week Low$21.59
52-Week Range
$21.59$25.68
$25.48
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield9.47%
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume10K
Avg Volume (10D)—
Shares Outstanding—
About ABXL
Abraxas BioScience (ABXL) is a biopharmaceutical innovator committed to addressing severe medical conditions with significant unmet needs through its robust pipeline of proprietary drug candidates. The company utilizes cutting-edge technologies in drug discovery to develop transformative therapies aimed at improving patient outcomes. With a strong focus on scientific integrity and regulatory adherence, ABXL collaborates with leading academic institutions and industry partners to enhance its research capabilities and accelerate the delivery of effective healthcare solutions.
NONENONE
Company Details
Security TypeNotes
ExchangeNYSE
CurrencyUSD
Round Lot—
SICNONE
CIK—
Composite FIGI—
Share Class FIGI—